Veren (TSE:VRN – Get Free Report) had its price objective cut by CIBC from C$13.00 to C$12.50 in a research note issued on Friday,BayStreet.CA reports. CIBC’s price objective suggests a potential upside of 58.03% from the company’s current price.
A number of other research analysts have also weighed in on VRN. National Bankshares cut their price objective on Veren from C$13.50 to C$13.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Royal Bank of Canada lowered their price target on shares of Veren from C$12.00 to C$10.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Canaccord Genuity Group lowered their price target on shares of Veren from C$15.00 to C$14.00 in a report on Tuesday, October 22nd. Raymond James lowered their price target on shares of Veren from C$13.00 to C$12.00 and set a “strong-buy” rating for the company in a report on Friday, November 1st. Finally, Scotiabank lowered their price target on shares of Veren from C$12.00 to C$11.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Six equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Veren has an average rating of “Buy” and a consensus price target of C$11.83.
Read Our Latest Stock Report on Veren
Veren Stock Performance
Veren Company Profile
Veren Inc explores, develops, and produces oil and gas properties in Canada and the United States. The company focuses on crude oil, tight oil, natural gas liquids, shale gas, and natural gas reserves. Its properties are located in the provinces of Saskatchewan, Alberta, British Columbia, and Manitoba; and the states of North Dakota.
Featured Articles
- Five stocks we like better than Veren
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- What Are Treasury Bonds?
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for Veren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veren and related companies with MarketBeat.com's FREE daily email newsletter.